A four-patient trial testing a unique type of mRNA cancer vaccine – NCI
Jul 3, 2024, 23:45

A four-patient trial testing a unique type of mRNA cancer vaccine – NCI

National Cancer Institute (NCI) shared a post on LinkedIn:

“Recent results from several small clinical trials have suggested it may be possible to develop an effective immunotherapy for glioblastoma. Among them are findings from a four-patient trial testing a unique type of mRNA cancer vaccine.”

Read further.
Source: NCI/LinkedIn